Simon N. Pimstone is of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 6,000 shares of XENE, which is worth approximately $230,520. The most recent transaction as insider was on Jun 01, 2023, when has been sold 31,713 shares (Common Shares) at a price of $38.88 per share, resulting in proceeds of $1,233,001. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
0% 3M change
0% 12M change
Total Value Held $230,520

SIMON N. PIMSTONE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2023
SELL
Open market or private sale
$1,233,001 $38.88 p/Share
31,713 Reduced 84.09%
6,000 Common Shares
Jun 01 2023
SELL
Payment of exercise price or tax liability
$870,970 $38.53 p/Share
22,605 Reduced 42.76%
30,255 Common Shares
Jun 01 2023
BUY
Exercise of conversion of derivative security
$691,468 $12.73 p/Share
54,318 Added 51.58%
51,000 Common Shares
May 31 2023
SELL
Open market or private sale
$2,418,505 $38.68 p/Share
62,526 Reduced 91.24%
6,000 Common Shares
May 31 2023
SELL
Payment of exercise price or tax liability
$1,124,586 $38.37 p/Share
29,309 Reduced 47.15%
32,856 Common Shares
May 31 2023
BUY
Exercise of conversion of derivative security
$1,102,521 $13.81 p/Share
79,835 Added 58.77%
56,000 Common Shares
May 30 2023
SELL
Open market or private sale
$1,453,225 $39.27 p/Share
37,006 Reduced 67.28%
18,000 Common Shares
Mar 07 2023
SELL
Open market or private sale
$711,007 $36.97 p/Share
19,232 Reduced 25.91%
55,006 Common Shares
Mar 07 2023
SELL
Payment of exercise price or tax liability
$140,277 $37.13 p/Share
3,778 Reduced 5.64%
63,248 Common Shares
Mar 07 2023
BUY
Exercise of conversion of derivative security
$190,122 $2.64 p/Share
72,016 Added 52.61%
64,866 Common Shares
Aug 16 2022
SELL
Open market or private sale
$2,008,398 $38.58 p/Share
52,058 Reduced 89.67%
6,000 Common Shares
Aug 15 2022
SELL
Open market or private sale
$1,281,650 $37.76 p/Share
33,942 Reduced 36.89%
58,058 Common Shares
Aug 12 2022
SELL
Open market or private sale
$3,513,254 $38.55 p/Share
91,135 Reduced 49.76%
92,000 Common Shares
Mar 08 2022
SELL
Open market or private sale
$377,744 $25.96 p/Share
14,551 Reduced 7.36%
183,135 Common Shares
Mar 07 2022
SELL
Payment of exercise price or tax liability
$60,158 $30.23 p/Share
1,990 Reduced 0.86%
228,772 Common Shares
Mar 07 2022
SELL
Open market or private sale
$948,434 $30.51 p/Share
31,086 Reduced 13.59%
197,686 Common Shares
Mar 07 2022
BUY
Exercise of conversion of derivative security
$75,514 $3.67 p/Share
20,576 Added 8.19%
230,762 Common Shares
Mar 04 2022
SELL
Open market or private sale
$285,438 $30.61 p/Share
9,325 Reduced 4.25%
210,186 Common Shares
Mar 04 2022
SELL
Payment of exercise price or tax liability
$30,257 $31.42 p/Share
963 Reduced 0.44%
219,511 Common Shares
Mar 04 2022
BUY
Exercise of conversion of derivative security
$37,757 $3.67 p/Share
10,288 Added 4.46%
220,474 Common Shares
Nov 15 2021
SELL
Open market or private sale
$550,061 $31.33 p/Share
17,557 Reduced 7.71%
210,186 Common Shares
May 24 2021
SELL
Payment of exercise price or tax liability
$97,307 $19.17 p/Share
5,076 Reduced 2.18%
227,743 Common Shares
May 24 2021
BUY
Exercise of conversion of derivative security
$85,100 $3.76 p/Share
22,633 Added 8.86%
232,819 Common Shares
SNP

Simon N. Pimstone

Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Track Activities on XENE